Intravesical Disitamab Vedotin (RC48) for HER2‐Expressing High‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Single‐Arm, Dose–Escalation Phase I Trial Study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Xu Chen, Ming Huang, Zehua Chen, Chengjunyu Zhang, Bolin Pan, Chu Liu, Wentong Xu, Jianmin Fang, Jian Huang, Tianxin Lin
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	MedComm
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet